Nephros (NEPH) Director Arthur H. Amron Receives 2,418-Share Award

What Happened

• Arthur H. Amron, a director of Nephros Inc. (NEPH), was issued 2,418 shares on August 12, 2026 as an award/compensation (Form 4 code A). The shares were acquired at $0 (issued in lieu of cash fees); the filing shows the acquisition value as $0 and the award is reported as fully vested.

Key Details

• Transaction date: 2026-08-12; Form 4 filed: 2026-08-14 (filed within the typical two-business-day window for Section 16 reporting).
• Transaction type/code: Award/Grant (A); acquisition price reported $0.
• Shares acquired: 2,418. Shares owned after transaction: not specified in the provided excerpt.
• Notable footnotes:
  • F1: Shares issued in lieu of cash fees for board service.
  • F2: Fully vested.
  • F3: Notes a separate option vesting schedule (2,350 shares vesting on each of 1/1/25, 1/1/26 and 1/1/27).
• No indication this was a sale or exercise; it was a direct issuance as compensation.

Context

• This was a compensation award (not a purchase or sale). Because the shares were issued in lieu of cash and are fully vested, Amron had immediate ownership and no cash outlay was reported.
• Awards and fees-in-kind are routine board compensation and do not by themselves signal insider buying/selling intent; they simply increase the insider’s stake immediately.